Quest PharmaTech to start Phase II Oregovomab clinical trial
Quest PharmaTech has got clearance from FDA to initiate US sites for an ongoing...
Bayer, Onyx Phase III NSCLC trial fails to meet primary endpoint
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that Phase III trial of Nexavar...
Active Biotech, Ipsen reach EUR10m milestone in Phase III study of tasquinimod
Active Biotech and Ipsen have announced the recruitment of 600 patients in randomized, placebo-controlled...
Peregrine reports results from phase II front-line lung cancer trial
Peregrine Pharmaceuticals has announced results from its randomized phase II trial, which is designed...
Circassia reports positive results from Phase II ragweed allergy therapy study
Circassia, a specialty biopharmaceutical company, has announced positive results from Phase II clinical trial...
PhaseBio begins Phase I hypertension study with Vasomera
PhaseBio Pharmaceuticals, a biotechnology company, has initiated Phase I clinical study with its novel...
TxCell reports positive immuno-monitoring results from Phase I/II Crohn’s disease study
TxCell SA, a biotechnology company, has announced positive immuno-monitoring results of the Phase I/II...
Galena initiates Phase III PRESENT trial for NeuVax
Galena Biopharma has initiated Phase III trial for NeuVax (E75 peptide plus GM-CSF) vaccine...
Genta reports Tesetaxel Phase 2b trial data
Genta's Tesetaxel has demonstrated efficacy in the Phase 2b, confirmatory clinical trial, designed to...
Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in...
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program...
